Jump Financial »

Amylyx Pharmaceuticals shares owned by Jump Financial

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-06-30 $306k 48k 6.41
2024-12-31 $394k 104k 3.78
2024-06-30 $34k 18k 1.90
2023-12-31 $196k 13k 14.72
2023-09-30 $418k 23k 18.31
2023-06-30 $3.1M 141k 21.57

More positions owned by Jump Financial

Invesco QQQ Trust Series 1 Etf (QQQ)
iShares Russell 2000 ETF Etf (IWM)
NVIDIA Corp Common Stock (NVDA)
SPDR S&P 500 ETF Trust Etf (SPY)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Consumer Discretionary Select Sector SPDR Fund Etf (XLY)
Broadcom Common Stock (AVGO)
iShares U.S. Treasury Bond ETF Etf (GOVT)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)

View all positions for Jump Financial

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals